Home > News > Rexahn, university partner for drug development
March 4th, 2006
Rexahn, university partner for drug development
Abstract:
The University of Maryland has teamed with Rexahn Pharmaceuticals to improve the company's drugs that treat cancer and central nervous system disorders. Researchers from the university's Center for Nanomedicine and Cellular Delivery in Baltimore will work with Rockville-based Rexahn to find new ways of applying nanotechnology research to make more effective drugs.
Source:
ACBJ
Bookmark:
| Related Links |
Center for Nanomedicine and Cellular Delivery
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||